Patent Yard Sign in
Expired Canadian patentCanada

Immunogenic hla-a2 supermotif-restricted peptides

CA 2432995 C · Owner: Sidney, John · Inventors: Southwood, Scott; Grey, Howard M.; Sette, Alessandro

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods to design vaccines which are effective in individuals bearing A2 supertype alleles are described. Single amino acid substitution analogs of known A2-supertype binding peptides, and large peptide libraries were utilized to rigorously define the peptide binding specificities of A2-supertype molecules. While each molecule was noted to have unique preferences large , overlaps in specificity were found. The presence of the hydrophobic and aliphatic residues L, I, V, M, A, T, and Q in positon 2 of peptide ligands was commonly tolerated by A2-supertype molecules. L I, V, M, A, and T were , tolerated at the C-terminus. While examination of secondary influences on peptide binding …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 29, 2002 and granted July 26, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 29, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 29, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 29, 2002
GrantedJuly 26, 2011
Term endedJanuary 29, 2022
Patent numberCA 2432995 C
Classification (IPC)G01N33/68 +1 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJan 29, 2002Patent grantedJuly 26, 2011Term endedJan 29, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.